Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 8 filers reported holding Astellas Pharma Inc in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,299 | -10.1% | 166 | -3.5% | 0.00% | – |
| Q2 2023 | $2,557 | +20.5% | 172 | +14.7% | 0.00% | – |
| Q1 2023 | $2,122 | +12.5% | 150 | +21.0% | 0.00% | – |
| Q4 2022 | $1,886 | -52.8% | 124 | -60.6% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 315 | +118.8% | 0.00% | – |
| Q2 2022 | $3,000 | +200.0% | 144 | +234.9% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 43 | +22.9% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -98.0% | 35 | -99.1% | 0.00% | – |
| Q1 2017 | $50,000 | -2.0% | 3,811 | +3.3% | 0.00% | – |
| Q4 2016 | $51,000 | -12.1% | 3,690 | -1.5% | 0.00% | – |
| Q3 2016 | $58,000 | – | 3,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE GROUP LLC | 1,006,415 | $15,080,000 | 0.60% |
| Henry James International Management Inc. | 18,078 | $271,000 | 0.12% |
| QUADRANT CAPITAL GROUP LLC | 27,557 | $407,000 | 0.07% |
| SCOUT INVESTMENTS, INC. | 210,640 | $3,156,000 | 0.06% |
| Aristotle Capital Management, LLC | 442,510 | $6,631,000 | 0.04% |
| BOSTON ADVISORS LLC | 43,966 | $658,000 | 0.03% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 2,560,399 | $38,329,000 | 0.03% |
| GLENMEDE TRUST CO NA | 306,283 | $4,588,000 | 0.02% |
| FULTON BANK, N.A. | 14,909 | $223,000 | 0.02% |
| Front Row Advisors LLC | 1,101 | $16,000 | 0.01% |